IMMUNOPRECISE ANTIBOD. earnings per share and revenue

TQB earnings per share for the last quarter are -0.08 EUR whereas the estimation was -0.07 EUR which accounts for -10.00% surprise. Företagets omsättning för samma period uppgår till 4.26 M EUR trots den uppskattade siffran 4.17 M EUR. Estimated earnings per share for the next quarter are -0.08 EUR, and revenue is expected to reach 4.44 M EUR. Also watch annual changes over time to get a bigger picture of TQB earnings per share and revenue dynamics.